Patents Assigned to LithoLyte Corporation, LLC
  • Dietary supplementation with mixed alkali salts
    Patent number: 11259553
    Abstract: The present invention provides compositions and methods for the dietary management of nephrolithiasis and hypocitraturia through the oral administration of multiple alkali salts including sodium bicarbonate, potassium citrate and/or magnesium citrate. Also provided are kits including compositions for the dietary management of nephrolithiasis and hypocitraturia.
    Type: Grant
    Filed: February 19, 2020
    Date of Patent: March 1, 2022
    Assignee: LithoLyte Corporation, LLC
    Inventor: Ryan Holland